Follow
Mary Figgatt
Title
Cited by
Cited by
Year
Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19
MC Figgatt, Z Salazar, E Day, L Vincent, N Dasgupta
Journal of Substance Abuse Treatment 123, 108276, 2021
1052021
Invited commentary: drug checking for novel insights into the unregulated drug supply
N Dasgupta, MC Figgatt
American Journal of Epidemiology 191 (2), 248-252, 2022
252022
Harmful algal bloom–associated illnesses in humans and dogs identified through a pilot surveillance system—New York, 2015
M Figgatt
MMWR. Morbidity and mortality weekly report 66, 2017
222017
Research led by people who use drugs: centering the expertise of lived experience
ZR Salazar, L Vincent, MC Figgatt, MK Gilbert, N Dasgupta
Substance abuse treatment, prevention, and policy 16, 1-4, 2021
212021
Associations of housing stress with later substance use outcomes: a systematic review
AE Austin, KY Shiue, RB Naumann, MC Figgatt, C Gest, ME Shanahan
Addictive Behaviors 123, 107076, 2021
202021
Giardiasis outbreak associated with asymptomatic food handlers in New York State, 2015
M Figgatt, K Mergen, D Kimelstein, DM Mahoney, A Newman, D Nicholas, ...
Journal of Food Protection 80 (5), 837-841, 2017
182017
Opioid overdose deaths among formerly incarcerated persons and the general population: North Carolina, 2000‒2018
SI Ranapurwala, MC Figgatt, M Remch, C Brown, L Brinkley-Rubinstein, ...
American Journal of Public Health 112 (2), 300-303, 2022
152022
Harmful algal bloom–associated illness surveillance: lessons from reported hospital visits in New York, 2008–2014
M Figgatt, N Muscatiello, L Wilson, D Dziewulski
American journal of public health 106 (3), 440-442, 2016
152016
Trends in unintentional polysubstance overdose deaths and individual and community correlates of polysubstance overdose, North Carolina, 2009-2018
MC Figgatt, AE Austin, ME Cox, S Proescholdbell, SW Marshall, ...
Drug and alcohol dependence 219, 108504, 2021
142021
Treatment experiences for skin and soft tissue infections among participants of syringe service programs in North Carolina
MC Figgatt, ZR Salazar, L Vincent, D Carden-Glenn, K Link, L Kestner, ...
Harm Reduction Journal 18, 1-9, 2021
112021
Reducing the harms of xylazine: clinical approaches, research deficits, and public health context
CM Zagorski, RA Hosey, C Moraff, A Ferguson, M Figgatt, S Aronowitz, ...
Harm reduction journal 20 (1), 141, 2023
102023
Chronic disease surveillance using electronic health records from health centers in a large urban setting
M Figgatt, J Chen, G Capper, S Cohen, R Washington
Journal of Public Health Management and Practice 27 (2), 186-192, 2021
102021
Susceptibility to hepatitis A and B virus among clients at a syringe services program in Philadelphia, 2018
M Figgatt, J Hildick-Smith, E Addish, J Coleman, J Benitez, C Freeland, ...
Public Health Reports 135 (5), 691-699, 2020
92020
Geographic Analysis of Blood Lead Levels and Neighborhood-Level Risk Factors Among Children Born in 2008–2010
E Taggert, M Figgatt, L Robinson, R Washington, N Kotkin, C Johnson
Journal of Environmental Health 82 (3), 18-25, 2019
82019
Inappropriate intravenous antimicrobial starts: An antimicrobial stewardship metric for hemodialysis facilities
PD Hahn, M Figgatt, T Peritz, SE Coffin
Infection Control & Hospital Epidemiology 40 (10), 1178-1180, 2019
52019
Naloxone buyers club: overlooked critical public health infrastructure for preventing overdose deaths
M Doe-Simkins, EJ Wheeler, MC Figgatt, TS Jones, A Bell, PJ Davidson, ...
medRxiv, 2021.11. 14.21266221, 2021
42021
Complications in using real-world data to study the health of people who use drugs
MC Figgatt, AJ Schranz, JM Hincapie-Castillo, YM Golightly, SW Marshall, ...
Epidemiology 34 (2), 259-264, 2023
32023
Adolescent and adult correlates of prescription opioid use and misuse in adulthood: Associations across domains of despair
AE Austin, RB Naumann, MC Figgatt, AE Aiello
Substance use & misuse 56 (3), 404-415, 2020
22020
A discussion of critical errors in a longitudinal study on the deterrent effect of drug‐induced homicide laws on opioid‐related mortality across 92 counties and the District of …
JJ Carroll, L Bevis, T El‐Sabawi, M Figgatt, N Dasgupta, L Beletsky, ...
World Medical & Health Policy 15 (4), 587-612, 2023
12023
Medications for Opioid Use Disorder and Mortality and Hospitalization Among People With Opioid Use-related Infections
MC Figgatt, JM Hincapie-Castillo, AJ Schranz, N Dasgupta, JK Edwards, ...
Epidemiology 35 (1), 7-15, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20